VarmX's Seed VC - II Round

VarmX raised a round of funding on June 27, 2017.

VarmX is a biotech company focusing on the development of therapies in the field of hemostasis and thrombosis. It is developing PseudoXa, a therapeutic protein to stop acute bleeding in patients takin…

Articles about VarmX's Seed VC - II Round: